SOMERSET, N.J. & SWINDON, United Kingdom--(BUSINESS WIRE)--Catalent Pharma Solutions, a leading global drug delivery technology company and Sanwa Kagaku Kenkyusho Co., Ltd, a leading Japanese pharmaceutical and health care company, have entered into an exclusive agreement to bring Sanwa’s innovative drug delivery tableting technology to global markets. This novel technology will be marketed by Catalent in all markets outside of Japan, Korea, China (Hong Kong), and Taiwan. OSDrC® is a fully developed optimized dose delivery technology and has already been commercially proven by Sanwa in Japan. Catalent will now utilize its global footprint, leading modified release delivery expertise, and integrated manufacturing know-how to bring OSDrC® to the global market. This technology enables significant improvements to therapeutic and drug delivery release profiles. It is anticipated that Catalent will commence customer product development trials at its Winchester, Kentucky facility in January, 2012.
